Patient-Reported Outcome Of Facial Erythema

Trial Profile

Patient-Reported Outcome Of Facial Erythema

Phase of Trial: Phase III

Latest Information Update: 01 Mar 2017

At a glance

  • Drugs Brimonidine (Primary)
  • Indications Rosacea
  • Focus Registrational; Therapeutic Use
  • Acronyms PROOF
  • Sponsors Galderma
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 24 Jan 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top